☆ 4.6 Article

Vaccine-Associated Uveitis after COVID-19 Vaccination

OPHTHALMOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, General & Internal

Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021

Matthew E. Oster et al.

Summary: Based on reports in the US, the risk of myocarditis after receiving mRNA-based COVID-19 vaccines was increased, especially among adolescent males and young men, particularly after the second dose. This risk should be considered in the context of the benefits of COVID-19 vaccination.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Review Immunology

Ocular Complications Following Vaccination for COVID-19: A One-Year Retrospective

Abid A. Haseeb et al.

Summary: This article provides a comprehensive review of ocular adverse events following COVID-19 vaccination, discussing manifestations and clinical courses in different parts of the eye, as well as proposed mechanisms. It is of great clinical value for ophthalmologists and primary care physicians.

VACCINES (2022)

添加到收藏夹

Article Clinical Neurology

Neurological Events Reported after COVID-19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System

Jennifer A. Frontera et al.

Summary: This study analyzed data collected from the US Vaccine Adverse Event Reporting System from January 1, 2021 to June 14, 2021. The study found that the rates of neurological events following COVID vaccination were rare, while the rates of neurological complications following acute COVID infection were significantly higher.

ANNALS OF NEUROLOGY (2022)

添加到收藏夹

Article Ophthalmology

Association between Vaccination with the BNT162b2 mRNA Coronavirus Disease 2019 Vaccine and Noninfectious Uveitis

Oren Tomkins-Netzer et al.

Summary: This study suggests an association between the BNT162b2 mRNA COVID-19 vaccine and an increased risk of active noninfectious uveitis (NIU). However, due to the small effect size and study limitations, this study does not provide proof for a cause-and-effect relationship. The small estimated attributable risks suggest that the impact on public health is relatively minor.

OPHTHALMOLOGY (2022)

添加到收藏夹

Article Ophthalmology

PERSPECTIVE COVID-19 Vaccination and The Eye

Michael T. M. Wang et al.

Summary: This article provides a summary of the latest evidence on COVID-19 vaccine-associated ocular adverse events through a narrative literature review. The data suggest that vaccination-associated ocular adverse events are very rare, and there is no evidence to suggest any negative effects of COVID-19 immunization in patients with pre-existing ophthalmic conditions.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2022)

添加到收藏夹

Article Ophthalmology

Association between Vaccination with the BNT162b2 mRNA Coronavirus Disease 2019 Vaccine and Noninfectious Uveitis A Population-Based Study

Oren Tomkins-Netzer et al.

Summary: This study assessed the association between BNT162b2 mRNA COVID-19 vaccine and the risk of active NIU. The results suggest that the vaccine may be associated with an increased risk of active NIU, but the small effect size and study limitations do not provide proof for a cause-and-effect relationship. The small estimated attributable risks suggest a relatively minor impact on public health.

OPHTHALMOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome, February-July 2021

Emily Jane Woo et al.

Summary: Based on data from the Vaccine Adverse Event Reporting System (VAERS) in the US, there have been 130 reports of presumptive Guillain-Barre syndrome (GBS) following receipt of the Ad26.COV2.S vaccine. The overall estimated observed to expected rate ratio was 4.18, indicating a potential safety concern for GBS. Further analysis of medical records is needed to establish a definitive diagnosis.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Multidisciplinary Sciences

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Zijun Wang et al.

Summary: Volunteers who received the Moderna or Pfizer-BioNTech vaccine showed high levels of antibodies and memory B cell responses against SARS-CoV-2, with activity similar to individuals who had recovered from natural infection. However, their efficacy against specific SARS-CoV-2 variants was reduced, indicating a potential need for periodic updates to mRNA vaccines to maintain clinical efficacy.

NATURE (2021)

添加到收藏夹

Letter Public, Environmental & Occupational Health

An interactive website tracking COVID-19 vaccine development

Madhumita Shrotri et al.

LANCET GLOBAL HEALTH (2021)

添加到收藏夹

Article Ophthalmology

Presence of SARS-CoV-2 Viral RNA in Aqueous Humor of Asymptomatic Individuals

Ellen H. Koo et al.

Summary: This study found the presence of SARS-CoV-2 viral RNA in the aqueous humor of asymptomatic individuals, even when nasal swab testing results were negative. This suggests that the virus may persist in immunoprivileged spaces despite the absence of symptoms.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)

添加到收藏夹

Article Immunology

Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)

Kerry J. Welsh et al.

Summary: This study analyzed VAERS reports of thrombocytopenia after vaccination with Pfizer-BioNTech COVID-19 Vaccine or Moderna COVID-19 Vaccine. The results showed a reporting rate of 0.80 per million doses for both vaccines, and the observed number of all thrombocytopenia cases following administration of mRNA COVID-19 vaccines is not greater than the number of ITP cases expected. Conclusion: The number of thrombocytopenia cases reported to VAERS does not suggest a safety concern attributable to mRNA COVID-19 vaccines at this time.

VACCINE (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines

Kellie D. Nance et al.

Summary: The COVID-19 mRNA vaccines have utilized the modified nucleobase N1-methylpseudouridine (m1 Psi) to enhance effectiveness, contributing to one of the most efficient vaccine development campaigns. By explaining the development and function of m1 Psi in synthetic mRNAs, this article aims to promote understanding and highlight potential opportunities for chemical innovation in the future.

ACS CENTRAL SCIENCE (2021)

添加到收藏夹

Article Psychology, Biological

A global database of COVID-19 vaccinations

Edouard Mathieu et al.

Summary: An effective rollout of COVID-19 vaccines is crucial in ending the pandemic, and Our World in Data's vaccination dataset tracks the progress and scale of vaccine distribution globally, aiding policymakers and researchers in understanding the global vaccination efforts.

NATURE HUMAN BEHAVIOUR (2021)

添加到收藏夹

Letter Pharmacology & Pharmacy

Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines

Maurizio Sessa et al.

Summary: This study looked at cases of thrombosis in women under 50 following Pfizer-BioNTech or Moderna COVID-19 vaccination in the US, and found that these events were not disproportionately reported compared to hormonal contraceptive use.

EXPERT OPINION ON DRUG SAFETY (2021)

添加到收藏夹

Article Ophthalmology

UVEITIS AFTER THE BNT162b2 mRNA VACCINATION AGAINST SARS-CoV-2 INFECTION A Possible Association

Tamar Rabinovitch et al.

Summary: This study describes uveitis cases following the administration of the BNT162b2 mRNA vaccine. Most cases presented as mild to moderate anterior uveitis, with a few developing multiple evanescent white dot syndrome.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2021)

添加到收藏夹

Review Medicine, General & Internal

Epidemiology and Risk Factors in Non-infectious Uveitis: A Systematic Review

Katherine A. Joltikov et al.

Summary: Non-infectious uveitis is a leading cause of vision loss worldwide, with an estimated prevalence of 121/100,000 in the United States. Females and individuals aged 20-50 are most affected, and risk factors include smoking, vitamin D deficiency, and the presence of other autoimmune diseases. Pregnancy appears to be protective against non-infectious uveitis, while certain medications and psychological stress may increase the risk.

FRONTIERS IN MEDICINE (2021)

添加到收藏夹

Review Surgery

Review the safety of Covid-19 mRNA vaccines: a review

Pratibha Anand et al.

Summary: Within the first year of the COVID-19 pandemic, over 100 million people globally have been infected, with a death toll surpassing 500,000 in the United States alone. The key to containing the pandemic lies in achieving herd immunity on a global scale, with at least 70-80% of the population needing to achieve active immunity against SARS-CoV-2.

PATIENT SAFETY IN SURGERY (2021)

添加到收藏夹

Article Ophthalmology

Prevalence of SARS-CoV-2 in human post-mortem ocular tissues

Onkar B. Sawant et al.

Summary: This study found a small but noteworthy prevalence of SARS-CoV-2 in ocular tissues from COVID-19 donors, highlighting the importance of stringent donor screening and disinfection protocols to prevent any tissue carrying SARS-CoV-2 from being used for corneal transplantation.

OCULAR SURFACE (2021)

添加到收藏夹

Article Ophthalmology

Case Report: Posterior Uveitis after Divalent Human Papillomavirus Vaccination in an Asian Female

Hongfei Ye et al.

OPTOMETRY AND VISION SCIENCE (2020)

添加到收藏夹

Article Immunology

The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barre syndrome

Elaine R. Miller et al.

VACCINE (2020)

添加到收藏夹

Editorial Material Ophthalmology

Vaccine-Associated Uveitis

Emmett T. Cunningham et al.

OCULAR IMMUNOLOGY AND INFLAMMATION (2019)

添加到收藏夹

Review Ophthalmology

A Focus on the Epidemiology of Uveitis

Theodora Tsirouki et al.

OCULAR IMMUNOLOGY AND INFLAMMATION (2018)

添加到收藏夹

Article Rheumatology

Exploring the variability in Behcet's disease prevalence: a meta-analytical approach

Carla Maldini et al.

RHEUMATOLOGY (2018)

添加到收藏夹

Article Ophthalmology

Bilateral Iritis after Vaccine for Bladder Cancer

Alberto Parafita-Fernandez et al.

OPTOMETRY AND VISION SCIENCE (2015)

添加到收藏夹

Article Pharmacology & Pharmacy

Human Papilloma Virus Vaccine Associated Uveitis

Henry D. Holt et al.

CURRENT DRUG SAFETY (2014)

添加到收藏夹

Article Pediatrics

Anterior Uveitis and Cataract After Rubella Vaccination: A Case Report of a 12-Month-Old Girl

Walter Ferrini et al.

PEDIATRICS (2013)

添加到收藏夹

Article Ophthalmology

Incidence and Prevalence of Uveitis Results From the Pacific Ocular Inflammation Study

Nisha R. Acharya et al.

JAMA OPHTHALMOLOGY (2013)

添加到收藏夹

Article Ophthalmology

Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reports

Frederick W. Fraunfelder et al.

CUTANEOUS AND OCULAR TOXICOLOGY (2010)

添加到收藏夹

Article Ophthalmology

Uveitis in a Patient Treated with Bacille-Calmette-Guerin Possible Antigenic Mimicry of Mycobacterial and Retinal Antigens

Aylin Garip et al.

OPHTHALMOLOGY (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.